Loading clinical trials...
Loading clinical trials...
As part of a post-approval commitment, the Korean health authority requests a study to characterize safety and effectiveness in patients treated with Koselugo (Selumetinib), an oral selective inhibito...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
AstraZeneca Clinical Study Information Center
CONTACT
1-877-240-9479information.center@astrazeneca.comLead Sponsor
AstraZeneca
NCT02390752 · Neurofibroma, Plexiform, Precursor Cell Lymphoblastic Leukemia-Lymphoma, and more
NCT04750928 · Neurofibromatosis 1
NCT05735717 · Hematologic Malignancy, Acute Leukemia, and more
NCT05361811 · Neurofibromatosis 1, Noonan Syndrome, and more
NCT04395495 · RAS Mutation, Neurofibromatosis 1, and more
Research Site
Busan
Research Site
Chungcheongbuk-do
Research Site
Daejeon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions